English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/111680
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 68 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Glutathione and mitochondria

Autor Ribas, Vicent; García-Ruiz, Carmen ; Fernández-Checa, José C.
Palabras clave Glutathione
Cholasteral
Mitochondrail
Reactive oxygen species
Steatohepatitis
Alzheimier disease
Fecha de publicación 1-jul-2014
EditorFrontiers Media
Citación Frontiers in Pharmacology 5:151 (2014)
ResumenGlutathione (GSH) is the main non-protein thiol in cells whose functions are dependent on the redox-active thiol of its cysteine moiety that serves as a cofactor for a number of antioxidant and detoxifying enzymes. While synthesized exclusively in the cytosol from its constituent amino acids, GSH is distributed in different compartments, including mitochondria where its concentration in the matrix equals that of the cytosol. This feature and its negative charge at physiological pH imply the existence of specific carriers to import GSH from the cytosol to the mitochondrial matrix, where it plays a key role in defense against respiration-induced reactive oxygen species and in the detoxification of lipid hydroperoxides and electrophiles. Moreover, as mitochondria play a central strategic role in the activation and mode of cell death, mitochondrial GSH has been shown to critically regulate the level of sensitization to secondary hits that induce mitochondrial membrane permeabilization and release of proteins confined in the intermembrane space that once in the cytosol engage the molecular machinery of cell death. In this review, we summarize recent data on the regulation of mitochondrial GSH and its role in cell death and prevalent human diseases, such as cancer, fatty liver disease, and Alzheimer's disease. © 2014 Ribas, Garcia-Ruiz and Fernandez-Checa.
Versión del editorhttp://dx.doi.org/10.3389/fphar.2014.00151
URI http://hdl.handle.net/10261/111680
DOI10.3389/fphar.2014.00151
Identificadoresdoi: 10.3389/fphar.2014.00151
issn: 1663-9812
Aparece en las colecciones: (IIBB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Ribas-Frontiers-Pharmacology-2014-5-151.pdf1,99 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.